388 related articles for article (PubMed ID: 31477055)
1. Human immunodeficiency virus-associated tuberculosis care in Botswana: evidence from a real-world setting.
Muyaya LM; Musanda EM; Tamuzi JL
BMC Infect Dis; 2019 Sep; 19(1):767. PubMed ID: 31477055
[TBL] [Abstract][Full Text] [Related]
2. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
Tshitenge S; Ogunbanjo GA; Citeya A
Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
[TBL] [Abstract][Full Text] [Related]
3. Predictors of mortality in adults on treatment for human immunodeficiency virus-associated tuberculosis in Botswana: A retrospective cohort study.
Muyaya LM; Young T; Loveday M
Medicine (Baltimore); 2018 Apr; 97(16):e0486. PubMed ID: 29668628
[TBL] [Abstract][Full Text] [Related]
4. National scale-up of tuberculosis-human immunodeficiency virus collaborative activities in Myanmar from 2005 to 2016 and tuberculosis treatment outcomes for patients with human immunodeficiency virus-positive tuberculosis in the Mandalay Region in 2015.
Theingi P; Harries AD; Wai KT; Shewade HD; Saw S; Win T; Thein S; Kyi MS; Nyunt Oo H; Aung ST
Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):402-409. PubMed ID: 29361150
[TBL] [Abstract][Full Text] [Related]
5. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
Atalell KA; Birhan Tebeje N; Ekubagewargies DT
PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596
[TBL] [Abstract][Full Text] [Related]
6. Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study.
Sileshi B; Deyessa N; Girma B; Melese M; Suarez P
BMC Infect Dis; 2013 Jul; 13():297. PubMed ID: 23815342
[TBL] [Abstract][Full Text] [Related]
7. HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town.
Kaplan R; Hermans S; Caldwell J; Jennings K; Bekker LG; Wood R
BMC Infect Dis; 2018 Jul; 18(1):356. PubMed ID: 30064368
[TBL] [Abstract][Full Text] [Related]
8. Operational research in Malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV.
Harries AD; Zachariah R; Chimzizi R; Salaniponi F; Gausi F; Kanyerere H; Schouten EJ; Jahn A; Makombe SD; Chimbwandira FM; Mpunga J
BMC Public Health; 2011 Jul; 11():593. PubMed ID: 21794154
[TBL] [Abstract][Full Text] [Related]
9. Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell counts.
Worodria W; Ssempijja V; Hanrahan C; Ssegonja R; Muhofwa A; Mazapkwe D; Mayanja-Kizza H; Reynolds SJ; Colebunders R; Manabe YC
AIDS; 2018 Sep; 32(15):2141-2149. PubMed ID: 30005014
[TBL] [Abstract][Full Text] [Related]
10. Assessing the accessibility of HIV care packages among tuberculosis patients in the Northwest Region, Cameroon.
Njozing NB; Miguel SS; Tih PM; Hurtig AK
BMC Public Health; 2010 Mar; 10():129. PubMed ID: 20226022
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaoundé Central Hospital, Cameroon: an 8-year hospital-based retrospective cohort study (2006-2013).
Agbor AA; Bigna JJ; Billong SC; Tejiokem MC; Ekali GL; Plottel CS; Noubiap JJ; Abessolo H; Toby R; Koulla-Shiro S
PLoS One; 2014; 9(12):e115211. PubMed ID: 25506830
[TBL] [Abstract][Full Text] [Related]
12. Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India.
Raizada N; Chauhan LS; Babu BS; Thakur R; Khera A; Wares DF; Sahu S; Bachani D; Rewari BB; Dewan PK
PLoS One; 2009 Jun; 4(6):e5999. PubMed ID: 19543396
[TBL] [Abstract][Full Text] [Related]
13. Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study.
Chanie ES; Gelaye GA; Tadesse TY; Feleke DG; Admas WT; Molla Alemu E; Azanaw MM; Tiruneh SA; Gebremariam AD; Birhane BM; Bayih WA; Aragie G
PLoS One; 2021; 16(12):e0258964. PubMed ID: 34932563
[TBL] [Abstract][Full Text] [Related]
14. [Effect of antiretroviral therapy in reducing deaths among patients co-infected with Mycobacterium tuberculosis and human immunodeficiency virus in Guangxi].
Zheng Z; Cui Z; Huang M; Pan D
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Feb; 36(2):124-7. PubMed ID: 25907719
[TBL] [Abstract][Full Text] [Related]
15. Bacteriologically confirmed tuberculosis in HIV-infected infants: disease spectrum and survival.
Wiseman CA; Schaaf HS; Cotton MF; Gie RP; Jennings T; Whitelaw A; Roux P; Hesseling AC
Int J Tuberc Lung Dis; 2011 Jun; 15(6):770-5. PubMed ID: 21575297
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database.
Han SH; Zhou J; Lee MP; Zhao H; Chen YM; Kumarasamy N; Pujari S; Lee C; Omar SF; Ditangco R; Phanuphak N; Kiertiburanakul S; Chaiwarith R; Merati TP; Yunihastuti E; Tanuma J; Saphonn V; Sohn AH; Choi JY;
HIV Med; 2014 Feb; 15(2):77-85. PubMed ID: 23980589
[TBL] [Abstract][Full Text] [Related]
17. Impact of ART on TB case fatality stratified by CD4 count for HIV-positive TB patients in Cape Town, South Africa (2009-2011).
Kaplan R; Caldwell J; Middelkoop K; Bekker LG; Wood R
J Acquir Immune Defic Syndr; 2014 Aug; 66(5):487-94. PubMed ID: 24820105
[TBL] [Abstract][Full Text] [Related]
18. Early Initiation of ARV Therapy Among TB-HIV Patients in Indonesia Prolongs Survival Rates!
Maemun S; Mariana N; Rusli A; Mahkota R; Purnama TB
J Epidemiol Glob Health; 2020 Jun; 10(2):164-167. PubMed ID: 32538033
[TBL] [Abstract][Full Text] [Related]
19. HIV screening among TB patients and level of antiretroviral therapy and co-trimoxazole preventive therapy for TB/HIV patients in Hawassa University Referral Hospital: a five year retrospective study.
Simieneh A; Hailemariam M; Amsalu A
Pan Afr Med J; 2017; 28():75. PubMed ID: 29255545
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm
Mutembo S; Mutanga JN; Musokotwane K; Alisheke L; Whalen CC
BMC Infect Dis; 2016 Oct; 16(1):572. PubMed ID: 27751168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
